• DM-β-Cyclodextrin Modulation of Mianserin HCl Cytotoxicity:

  2026-04-28

  This study investigates the interaction between mianserin hydrochloride (Mianserin HCl), a tetracyclic antidepressant and 5-HT2 receptor antagonist, and heptakis (2,6-di-O-methyl)-β-cyclodextrin (DM-β-CD). Using calorimetry, spectroscopy, and cell viability assays, the research demonstrates that DM-β-CD inclusion increases, rather than decreases, mianserin’s cytotoxicity in hamster cell models. These results refine the understanding of cyclodextrin-based modulation of drug toxicity with implications for antidepressant research compound optimization.

• SEMA3E Drives Beige Adipocyte Thermogenesis via β-Catenin in

  2026-04-28

  This study demonstrates that SEMA3E, a class 3 semaphorin, is a critical regulator of beige adipocyte differentiation and thermogenesis in mice, acting through the Wnt/β-catenin signaling pathway. These findings clarify how SEMA3E integrates environmental cues to modulate adipose tissue function, with implications for metabolic disease research.

• 2-NBDG (SKU B6035): Reliable Glucose Uptake Measurement in C

  2026-04-27

  This article addresses common laboratory challenges in quantifying cellular glucose uptake using 2-NBDG (SKU B6035). Through evidence-based, scenario-driven Q&A, we demonstrate how 2-NBDG supports reproducible, sensitive, and workflow-compatible assays in research on diabetes, cancer, and metabolic disorders.

• GW4064: FXR Agonist Innovation for Advanced Fibrosis Researc

  2026-04-27

  Explore how GW4064, a potent non-steroidal FXR agonist, enables advanced investigation of bile acid metabolism and fibrosis pathways. This article uniquely deciphers recent mechanistic insights and practical assay implications for metabolic research.

• BET Protein Inhibition Disrupts HPV-16 HNSCC Transcriptional

  2026-04-26

  This study investigates how chemical inhibition of BET bromodomain proteins, specifically BRD4, alters viral and cellular gene expression in HPV-16 associated head and neck squamous cell carcinoma (HNSCC). The findings reveal a heterogeneous transcriptional response to BET inhibition, with implications for both cancer biology research and targeted therapeutic strategies.

• Miltefosine in Hematology: Applied Protocols and Troubleshoo

  2026-04-25

  Miltefosine, a PI3K/Akt pathway inhibitor and Ras/MEK/ERK activator, is redefining neutrophil differentiation assays and leukemia models. This guide translates the latest mechanistic findings into actionable workflows, with practical troubleshooting for maximizing research impact.

• UTP Solution (100 mM): Precision RNA Synthesis & Metabolic I

  2026-04-24

  APExBIO’s UTP Solution (100 mM) empowers high-fidelity in vitro transcription, RNA amplification, and metabolic research with unmatched purity. This guide translates cutting-edge reference findings into actionable workflows, protocol optimization, and troubleshooting strategies for advanced molecular biology labs.

• Phosbind Biotin: Dinuclear Metal Complex for Phosphorylation

  2026-04-24

  Phosbind Biotin empowers rapid, sequence-independent detection of phosphorylated proteins in Western Blot workflows, outperforming traditional antibody-based methods in certain experimental contexts. Its dinuclear metal complex phosphate binding enables robust analysis of phosphorylation-driven signaling, unlocking new insights in plant stress biology and beyond.

• Trelagliptin Succinate in Experimental Type 2 Diabetes Resea

  2026-04-23

  Trelagliptin succinate (SYR-472 succinate) is redefining type 2 diabetes and metabolic research with its potent, selective DPP-4 inhibition and multi-pathway efficacy. This guide delivers detailed workflows, troubleshooting strategies, and new mechanistic insights to maximize experimental outcomes using APExBIO’s high-purity compound.

• Saquinavir: Optimizing HIV Protease Inhibitor Workflows

  2026-04-23

  Saquinavir enables robust, reproducible inhibition of HIV-1 and HIV-2 proteases, serving as a benchmark in antiretroviral drug research and beyond. This article delivers actionable protocols, comparative innovations, and troubleshooting strategies to maximize the impact of Saquinavir in both virology and emerging cancer research.

• Phenacetin for Translational Research: Mechanisms and Strate

  2026-04-22

  Explore the evolving role of Phenacetin (N-(4-ethoxyphenyl)acetamide) in translational science, bridging mechanistic insight with actionable strategies for researchers. This thought-leadership piece details its molecular rationale, experimental validation, competitive landscape, and clinical relevance, while providing protocol guidance and a forward-looking outlook. Leveraging internal assets and literature, this article clarifies why APExBIO's Phenacetin sets a new standard for reproducibility and research-grade reliability.

• Renin–Angiotensin System Peptides and SARS-CoV-2 Entry via A

  2026-04-22

  This study rigorously investigates how peptides of the renin–angiotensin system (RAS), particularly angiotensin II and angiotensin IV, modulate SARS-CoV-2 entry through the ACE2 receptor. The key finding is that angiotensin IV, but not angiotensin II, enhances viral entry at certain concentrations, suggesting a novel mechanism linking RAS peptide dynamics with COVID-19 susceptibility and pathogenesis.

• Necrosulfonamide (SKU B7731): Precision Tools for Necroptosi

  2026-04-21

  This article delivers laboratory-tested, scenario-driven guidance for using Necrosulfonamide (SKU B7731) to solve common challenges in necroptosis assay design and cell death pathway research. Evidence, protocol parameters, and vendor comparisons help researchers optimize experimental reliability and data interpretation when dissecting MLKL-mediated necroptosis.

• Stiripentol: Precision LDH Inhibition for Lactate-Driven Epi

  2026-04-21

  Explore how Stiripentol, a novel LDH inhibitor, uniquely enables precision modulation of lactate metabolism and histone lactylation in advanced neuroepileptic and tumor microenvironment research. Gain new assay insights and practical protocols for leveraging lactate-to-pyruvate conversion inhibition.

• FAPα-Responsive Nanoparticles for Noninvasive Solid Tumor Di

  2026-04-20

  This study introduces a synthetic urinary probe–coated magnetic nanoparticle system that enables noninvasive diagnosis of FAPα-positive solid tumors through urine biomarker release. The approach demonstrates high specificity and diagnostic accuracy, offering a significant advance in the detection and monitoring of tumor microenvironment activity.

451 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page